Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Hyperlipidemia Drugs Market Report by Drug Type (Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A2685
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Hyperlipidemia Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Type
6.1 Statins
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Bile Acid Sequestrants
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Cholesterol Absorption Inhibitors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 PCSK9 Inhibitors
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by End User
7.1 Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Clinics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Amgen Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 AstraZeneca Plc
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Daiichi Sankyo Company Limited
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Eli Lilly and Company
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Esperion Therapeutics Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 GlaxoSmithKline Pharmaceuticals Limited (GlaxoSmithKline Plc)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Immuron Limited
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.8 Ionis Pharmaceuticals Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Merck & Co. Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Pfizer Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Sanofi S.A.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Hyperlipidemia Drugs Market: Major Drivers and Challenges
Figure 2: Global: Hyperlipidemia Drugs Market: Sales Value (in Billion USD), 2018-2023
Figure 3: Global: Hyperlipidemia Drugs Market: Breakup by Drug Type (in %), 2023
Figure 4: Global: Hyperlipidemia Drugs Market: Breakup by End User (in %), 2023
Figure 5: Global: Hyperlipidemia Drugs Market: Breakup by Region (in %), 2023
Figure 6: Global: Hyperlipidemia Drugs Market Forecast: Sales Value (in Billion USD), 2024-2032
Figure 7: Global: Hyperlipidemia Drugs (Statins) Market: Sales Value (in Million USD), 2018 & 2023
Figure 8: Global: Hyperlipidemia Drugs (Statins) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 9: Global: Hyperlipidemia Drugs (Bile Acid Sequestrants) Market: Sales Value (in Million USD), 2018 & 2023
Figure 10: Global: Hyperlipidemia Drugs (Bile Acid Sequestrants) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 11: Global: Hyperlipidemia Drugs (Cholesterol Absorption Inhibitors) Market: Sales Value (in Million USD), 2018 & 2023
Figure 12: Global: Hyperlipidemia Drugs (Cholesterol Absorption Inhibitors) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 13: Global: Hyperlipidemia Drugs (PCSK9 Inhibitors) Market: Sales Value (in Million USD), 2018 & 2023
Figure 14: Global: Hyperlipidemia Drugs (PCSK9 Inhibitors) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 15: Global: Hyperlipidemia Drugs (Other Drug Types) Market: Sales Value (in Million USD), 2018 & 2023
Figure 16: Global: Hyperlipidemia Drugs (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 17: Global: Hyperlipidemia Drugs (Hospitals) Market: Sales Value (in Million USD), 2018 & 2023
Figure 18: Global: Hyperlipidemia Drugs (Hospitals) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 19: Global: Hyperlipidemia Drugs (Clinics) Market: Sales Value (in Million USD), 2018 & 2023
Figure 20: Global: Hyperlipidemia Drugs (Clinics) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 21: Global: Hyperlipidemia Drugs (Other End Users) Market: Sales Value (in Million USD), 2018 & 2023
Figure 22: Global: Hyperlipidemia Drugs (Other End Users) Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 23: North America: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 24: North America: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 25: United States: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 26: United States: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 27: Canada: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 28: Canada: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 29: Asia Pacific: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 30: Asia Pacific: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 31: China: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 32: China: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 33: Japan: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 34: Japan: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 35: India: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 36: India: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 37: South Korea: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 38: South Korea: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 39: Australia: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 40: Australia: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 41: Indonesia: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 42: Indonesia: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 43: Others: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 44: Others: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 45: Europe: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 46: Europe: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 47: Germany: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 48: Germany: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 49: France: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 50: France: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 51: United Kingdom: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 52: United Kingdom: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 53: Italy: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 54: Italy: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 55: Spain: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 56: Spain: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 57: Russia: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 58: Russia: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 59: Others: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 60: Others: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 61: Latin America: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 62: Latin America: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 63: Brazil: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 64: Brazil: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 65: Mexico: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 66: Mexico: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 67: Others: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 68: Others: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 69: Middle East and Africa: Hyperlipidemia Drugs Market: Sales Value (in Million USD), 2018 & 2023
Figure 70: Middle East and Africa: Hyperlipidemia Drugs Market Forecast: Sales Value (in Million USD), 2024-2032
Figure 71: Global: Hyperlipidemia Drugs Industry: SWOT Analysis
Figure 72: Global: Hyperlipidemia Drugs Industry: Value Chain Analysis
Figure 73: Global: Hyperlipidemia Drugs Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Hyperlipidemia Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Hyperlipidemia Drugs Market Forecast: Breakup by Drug Type (in Million USD), 2024-2032
Table 3: Global: Hyperlipidemia Drugs Market Forecast: Breakup by End User (in Million USD), 2024-2032
Table 4: Global: Hyperlipidemia Drugs Market Forecast: Breakup by Region (in Million USD), 2024-2032
Table 5: Global: Hyperlipidemia Drugs Market Structure
Table 6: Global: Hyperlipidemia Drugs Market: Key Players
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
Read More
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested
Read More
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
Read More
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
Read More
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
Read More
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
Read More
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
Read More
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
Read More
The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.
Read More
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Read More
The report is excellent and has good amount of data and our team is extremely happy with the information provided.
Read More
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.
Read More